Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women

Neuropsychopharmacology

Volumn 31, Issue 4, 2006, Pages 885-889

  Gogos, Andrea ^a   Nathan, Pradeep J ^b   Guille, Valérie ^c   Croft, Rodney J ^c   Van Den Buuse, Maarten ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Buspirone; EMG; Estradiol; Human; Schizophrenia; Serotonin

Indexed keywords

BUSPIRONE; ESTROFEM; ESTROGEN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

ADULT; AMPLITUDE MODULATION; ARTICLE; DRUG EFFECT; ELECTROMYOGRAM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HABITUATION; HUMAN; MENTAL DISEASE; NEUROPROTECTION; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SENSORIMOTOR NEUROPATHY; STARTLE REFLEX;

ACOUSTIC STIMULATION; ADULT; ANALYSIS OF VARIANCE; BUSPIRONE; DOUBLE-BLIND METHOD; ESTROGENS; FEMALE; HUMANS; NEURAL INHIBITION; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; STARTLE REACTION;

EID: 33645019221     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300933     Document Type: Article

References (38)

1. Anokhin AP, Heath AC, Myers E, Ralano A, Wood S (2003). Genetic influences on prepulse inhibition of startle reflex in humans. Neurosci Lett 353: 45-48.
2. 1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15: 37-46.
3. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
4. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30: 565-574.
5. Cadenhead KS, Geyer MA, Braff DL (1993). Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150: 1862-1867.
6. Canuso CM, Goldstein JM, Green AI (1998). The evaluation of women with schizophrenia. Psychopharmacol Bull 34: 271-277.
7. Filion DL, Dawson ME, Schell AM (1993). Modification of the acoustic startle-reflex eyeblink: a tool for investigating early and late attentional processes. Biol Psychol 35: 185-200.
8. Fink BJ, Christensen MS (1981). Bioavailability of oestradiol and oestriol administered orally to oophorectomized women. Maturitas 3: 289-294.
9. 1A - receptor binding in the brain of cyclic and ovariectomized female rats. J Neuroendocrinol 11: 243-249.
10. Furuhjelm M, Karlgren E, Carlstrom K (1984). The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 63: 655-661.
11. Ganong WF (1979). Review of Medical Physiology. Lange Medical Publications: CA, USA. pp 340-350.
12. Gogos A, Van den Buuse M (2003). Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behav Neurosci 117: 1407-1415.
13. Gogos A, Van den Buuse M (2004). Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309: 267-274.
14. Häfner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W (1993). Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23: 925-940.
15. Hellewell JS, Guimaraes FS, Wang M, Deakin JF (1999). Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans. J Psychopharmacol 13: 122-127.
16. Jackson A, Etgen AM (2001). Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT. Pharmacol Biochem Behav 68: 221-227.
17. Johansson C, Jackson DM, Zhang J, Svensson L (1995). Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol Biochem Behav 52: 649-654.
18. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A et al (2004). Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41: 401-406.
19. Kodsi MH, Swerdlow NR (1994). Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res 643: 59-65.
20. Kulkarni J, Riedel A, de Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J et al (2001). Estrogen - a potential treatment for schizophrenia. Schizophr Res 48: 137-144.
21. Kumari V, Aasen I, Sharma T (2004). Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr Res 69: 219-235.
22. Kumari V, Soni W, Mathew VM, Sharma T (2000). Prepulse inhibition of the startle response in men with schizophrenia. Arch Gen Psychiatry 57: 609-614.
23. Landry M, Di Paolo T (2003). Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Mol Brain Res 112: 82-89.
24. Lechin F, van der Dijs B, Jara H, Orozco B, Baez S, Benaim M et al (1998). Effects of buspirone on plasma neurotransmitters in healthy subjects. J Neural Transm 105: 561-573.
25. 35S] GTPgammaS binding. Brain Res 859: 326-333.
26. Mize AL, Poisner AM, Alper RH (2001). Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73: 166-174.
27. Mizuki Y, Suetsugi M, Ushijima I, Yamada M (1994). Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Methods Find Exp Clin Pharmacol 16: 291-300.
28. Okazawa H, Yamane F, Blier P, Diksic M (1999). Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain. J Neurochem 72: 2022-2031.
29. Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R et al (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47: 662-669.
30. Phillips MA, Oxtoby EK, Langley RW, Bradshaw CM, Szabadi E (2000). Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 14: 258-265.
31. Rigdon GC, Weatherspoon JK (1992). 5-Hydroxytryptamine1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263: 486-493.
32. Seeman MV, Lang M (1990). The role of estrogens in schizophrenia gender differences. Schizophr Bull 16: 185-194.
33. 1A receptors in ventral prefrontal cortex in schizophrenia. Biol Psychiatry 39: 919-928.
34. Sipes TA, Geyer MA (1995). 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology (Berl) 117: 41-48.
35. Sipos ML, Bauman RA, Widholm JJ, Kant GJ (2000). Behavioral effects of 8-OH-DPAT in chronically stressed male and female rats. Pharmacol Biochem Behav 66: 403-411.
36. Swerdlow NR, Hartman PL, Auerbach PP (1997). Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 41: 452-460.
37. Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001). Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 158: 230-240.
38. VanderMaelen CP, Matheson GK, Wilderman RC, Patterson LA (1986). Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol 129: 123-130.